These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1911387)

  • 1. Co-expression of myeloid antigens in childhood acute lymphoblastic leukaemia: relationship with the stage of differentiation and clinical significance.
    Cantù-Rajnoldi A; Putti C; Saitta M; Granchi D; Foà R; Schirò R; Castagni M; Valeggio C; Jankovic M; Miniero R
    Br J Haematol; 1991 Sep; 79(1):40-3. PubMed ID: 1911387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia.
    Pui CH; Rubnitz JE; Hancock ML; Downing JR; Raimondi SC; Rivera GK; Sandlund JT; Ribeiro RC; Head DR; Relling MV; Evans WE; Behm FG
    J Clin Oncol; 1998 Dec; 16(12):3768-73. PubMed ID: 9850020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones.
    Firat H; Favier R; Adam M; Leverger G; Landman-Parker J; Cayre Y; Douay L
    Leuk Lymphoma; 2001 Jun; 42(1-2):75-82. PubMed ID: 11699224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones.
    Firat H; Favier R; Adam M; Leverger G; Landman-Parker J; Cayre Y; Douay L
    Leuk Lymphoma; 2001 Aug; 42(4):675-82. PubMed ID: 11697497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of myeloid-associated antigen expression on blast cells in children with acute lymphoblastic leukemia. The Austrian Pediatric Oncology Group.
    Fink FM; Köller U; Mayer H; Haas OA; Grümayer-Panzer ER; Urban C; Dengg K; Mutz I; Tüchler H; Gatterer-Menz I
    Med Pediatr Oncol; 1993; 21(5):340-6. PubMed ID: 8492748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia.
    Urbano-Ispizua A; Matutes E; Villamor N; Ribera JM; Feliu E; Montserrat E; Grañena A; Vives-Corrons JL; Rozman C
    Br J Haematol; 1990 Jun; 75(2):202-7. PubMed ID: 2372506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A subset of acute lymphoblastic leukemia with co-expression of myeloid antigens: prevalence and clinical significance.
    Hsu PN; Tien HF; Wang CH; Chen YC; Shen MC; Lin DT; Lin KH; Liang DC; Lin KS
    J Formos Med Assoc; 1991 Mar; 90(3):225-31. PubMed ID: 1677396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
    Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia.
    Drexler HG; Thiel E; Ludwig WD
    Leukemia; 1991 Aug; 5(8):637-45. PubMed ID: 1886419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute biphenotypic leukaemia: immunophenotypic and cytogenetic analysis.
    Hanson CA; Abaza M; Sheldon S; Ross CW; Schnitzer B; Stoolman LM
    Br J Haematol; 1993 May; 84(1):49-60. PubMed ID: 7687860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy.
    Pui CH; Behm FG; Singh B; Rivera GK; Schell MJ; Roberts WM; Crist WM; Mirro J
    Blood; 1990 Jan; 75(1):198-202. PubMed ID: 2294988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of standard CD assessment in acute leukemia.
    Tupitsyn NN; Babusíková O; Baryshnikov AYu ; Ujházy P; Kadagidze ZG; Mahonova LA; Peterson IS; Protasova AK; Drozdova TS; Artemjev AK
    Neoplasma; 1990; 37(4):431-8. PubMed ID: 2146517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
    Wiersma SR; Ortega J; Sobel E; Weinberg KI
    N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression pattern of hybrid phenotype in adult acute lymphoblastic leukemia.
    Nakase K; Kita K; Miwa H; Nishii K; Shiku H; Nasu K; Dohy H; Kyo T; Kamada N; Tsutani H
    Cancer Detect Prev; 2001; 25(4):394-405. PubMed ID: 11531016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens.
    Syrjälä M; Anttila VJ; Ruutu T; Jansson SE
    Leukemia; 1994 Sep; 8(9):1564-70. PubMed ID: 7522295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
    van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications.
    Lauria F; Raspadori D; Martinelli G; Rondelli D; Ventura MA; Farabegoli P; Tosi P; Testoni N; Visani G; Zaccaria A
    Br J Haematol; 1994 Jun; 87(2):286-92. PubMed ID: 7947269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms.
    Nakase K; Kita K; Shiku H; Tanaka I; Nasu K; Dohy H; Kyo T; Tsutani H; Kamada N
    Am J Clin Pathol; 1996 Jun; 105(6):761-8. PubMed ID: 8659452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.